Speaker illustration

Doctor Elham Kayvanpour

University Hospital of Heidelberg, Heidelberg (Germany)

Member of:

European Society of Cardiology

Dr. Kayvanpour started her medical studies in Iran. She then moved to Germany and continued her studies in Heidelberg. In 2012 she started her career as a physician scientist in the cardiology department of University Hospital Heidelberg. Her special interests are heart failure and genetic cardiomyopathies. Her research fields are molecular, functional and clinical genetics, computational prediction of clinical therapies, and cardiac biomarkers. Dr. Kayvanpour has been awarded with many prizes and scholarships including “Dres. Majic/Majic-Schlez-Stiftung", "Research Award Dresdner Herz-Kreislauf-Tage", and "DZHK Rotation grant". She won the title “primus inter pares” in the ESC Quiz in 2017.

Precision medicine: myocardial fibrosis burden and genotype predict outcome in non-ischemic dilated cardiomyopathy (DCM)

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Circulating and Imaging Biomarkers in Heart Failure

Thumbnail

Left ventricular non-compaction, trait or cardiomyopathy

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Inflammatory and infiltrative cardiography

Thumbnail

Collagen volume fraction, MMP-2, TIMP-1, GDF-15, and OPN are predictors of adverse outcome in non-ischemic dilated cardiomyopathy

Event: ESC CONGRESS 2017

Topic: Prognosis

Session: Chronic heart failure (CHF)

Thumbnail

Does it matter which gene? A meta-analysis on genotype-phenotype association in dilated cardiomyopathy

Event: ESC CONGRESS 2016

Topic: Heart failure, other

Session: Heart failure/Left ventricular function

Thumbnail

Measurement of extracellular volume fraction (ECV) in left ventricular endomyocardial biopsy can estimate outcome and help to individualize therapy in heart failure patients

Event: ESC CONGRESS 2016

Topic: Prognosis

Session: Heart failure / LV dysfunction

Thumbnail

This platform is supported by

logo Novo Nordisk